"Unsere Klinik ist ein Referenzzentrum mit weltweiter Reputation für die Abklärung, Behandlung und Prävention von Krankheiten der Haut, der Nägel und der Haare. Als akademisches Zentrum arbeiten wir intensiv an Verbesserungen bei Diagnose und Behandlung unter kontrollierten Bedingungen (klinischen Studien)."

During the past decade, Universitätsspital Zürich, Dermatologische Klinik conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsspital Zürich, Dermatologische Klinik" #1 sponsor was "University of Zurich" with 28 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Eisai Inc." with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Onxeo" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsspital Zürich, Dermatologische Klinik" #1 collaborator was "ADR-AC Laboratory, Berne" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Cork University Hospital" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsspital Zürich, Dermatologische Klinik" are "Lymphoma, T-Cell, Cutaneous" (4 trials), "Atopic Dermatitis" (3 trials), "Food Allergy" (3 trials), "Malignant Melanoma" (3 trials) and "Melanoma" (3 trials). Many other conditions were trialed in "Universitätsspital Zürich, Dermatologische Klinik" in a lesser frequency.

Most popular intervention types in "Universitätsspital Zürich, Dermatologische Klinik" are "Drug" (21 trials), "Device" (10 trials), "Other" (6 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "APO866" (2 trials), "ONTAK" (2 trials), "Placebo" (2 trials), "SOCKNLEG" (2 trials) and "(Socknleg)To done of a novel compression system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsspital Zürich, Dermatologische Klinik" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsspital Zürich, Dermatologische Klinik". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Universitätsspital Zürich, Dermatologische Klinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsspital Zürich, Dermatologische Klinik, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".